CI Canadian Convertible Bond ETF Common (TSE:CXF – Get Free Report) traded up 0.1% during trading on Monday . The stock traded as high as C$10.16 and last traded at C$10.15. 1,393 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 5,740 shares. The stock had previously closed at C$10.14.
CI Canadian Convertible Bond ETF Common Price Performance
The firm has a 50 day moving average price of C$10.22 and a 200 day moving average price of C$10.07.
About CI Canadian Convertible Bond ETF Common
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company’s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
See Also
- Five stocks we like better than CI Canadian Convertible Bond ETF Common
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- How to Invest in Small Cap Stocks
- What is Put Option Volume?
- These Are the Dividend Stocks Insiders Bought in January
- Top Biotech Stocks: Exploring Innovation Opportunities
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for CI Canadian Convertible Bond ETF Common Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Canadian Convertible Bond ETF Common and related companies with MarketBeat.com's FREE daily email newsletter.
